Document is current
Any future updates will be listed below
-
Authors
Sun, Yiting
Xu, Lei
Deng, Chaoqiang
Du, Xinyang
Yu, Yongkui
Hao, Yuan
Wang, Huijuan
Wang, Xin
Zhang, Yang
Chen, Haiquan https://orcid.org/0000-0001-7846-257X
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81930073)
National Natural Science Foundation of China (82373309)
National Natural Science Foundation of China (82403232)
the National Key R&D Program of China (2022YFA1103900)
the National Key R&D Program of China (2019YFA0905900)
the Cooperation Project of Conquering Major Diseases in Xuhui District (XHLHGG202101)
China Postdoctoral Science Foundation (2024M750534)
- License Information
-
More Information
Article History
Received: 10 September 2024
Revised: 7 October 2025
Accepted: 9 October 2025
First Online: 30 October 2025
Declarations
:
: The study was approved by the Ethics Committee of Fudan University Shanghai Cancer Center (IRB-2008223-9), the Ethics Committee of Shanxi Province Cancer Hospital (KY2024052), and Institutional Ethics Committee of Henan Cancer Hospital affiliated to Zhengzhou University (Approval number 2017407). This study was registered on ClinicalTrials.gov (NCT06164574). Informed written consent was obtained from all patients.
: Consent for publication of patients’ clinical information (including clinical symptoms, biochemistry examination, tumor specimen, and radiology imaging) was obtained with the permission of by the ethics committees of all the participating centers. None of the identifiable information of enrolled patients was used or leaked in this study.
: The authors declare that they have no competing interest.
